Opposition 91305095
SuspendedUSPTO
Opposition 91305095 at USPTO between Cory Laboratories, Inc. and Selectpharma, S.A., over the mark TRIPLEX, filed Feb 6, 2026. Status in the office record: suspended.
- Status
- Suspended
- Filed
- Feb 6, 2026
- Marks involved
- 4
Parties
Who is involved
The parties as named in the office record.
Opponent
Cory Laboratories, Inc.
Respondent
Selectpharma, S.A.
Timeline
How the case has moved
Dates from the USPTO record and the TRIPLEX filing.
TRIPLEX filed
Application 99335962 filed at the USPTO.Opposition filed
Cory Laboratories, Inc. started opposition 91305095 at USPTO against TRIPLEX.- Next
Suspended
No decision is recorded at USPTO yet.
Marks
Marks involved
1 contested mark, 3 marks the challenger relies on.
| Mark | Role | Application | Office |
|---|---|---|---|
| TRIPLEX | Contested | 99335962 | USPTO |
| TRIPLE XXX | Relied on | 87817631 | USPTO |
| TRIPLE XXX | Relied on | 87817648 | USPTO |
| TRIPLE XXX | Relied on | 87818330 | USPTO |
API
Get this data via the API
Every fact on this page comes from the Signa API. Track oppositions and cancellations on any mark with one request.
GET/v1/proceedings/{id}Parties, dates, outcome and every mark in the case
GET/v1/proceedings?trademark_id={trademark_id}Every proceeding on a mark
GET /v1/proceedings/{id}
ID=prc_5fc21b1c-921d-4662-a042-63d8d60f1235
curl https://api.signa.so/v1/proceedings/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"Response
{
"id": "prc_5fc21b1c-921d-4662-a042-63d8d60f1235",
"object": "proceeding",
"proceeding_type": "opposition",
"proceeding_number": "91305095",
"status": "suspended",
"office_code": "US",
"filed_date": "2026-02-06",
"parties": [
{
"name": "Cory Laboratories, Inc.",
"role": "opponent"
},
{
"name": "Selectpharma, S.A.",
"role": "respondent"
}
]
}